Edvard Marinovskij
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Edvard Marinovskij has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Margit Dueholm
Department of Obstetrics and Gynecology Aarhus University Hospital Aarhus Denmark
3 shared publications - Anne Gisselmann Egekvist
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
2 shared publications - Axel Forman
Department of Obstetrics and Gynecology Aarhus University Hospital Aarhus Denmark
2 shared publications - Ulrik Schiøler Kesmodel
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
2 shared publications - Anneli C. S. Bolund
Department of Clinical Genetics Aarhus University Hospital Aarhus Denmark
1 shared publication - Dorte Launholt Lildballe
Department of Clinical Medicine Aarhus University Aarhus Denmark
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by Wiley in Clinical Genetics
Müllerian Duct Aplasia in a Girl With SMARCB1 ‐Related Coffin–Siris Syndrome: A Rare Co‐Occurring Anomaly
Genetic etiologies of Müllerian aplasia (Mayer–Rokitansky–Küster–Hauser syndrome) remain poorly understood. Identification of patients with monogenic syndromes presenting with Müllerian aplasia may help improve our knowledge of the underlying biology. We investigated a 15‐year‐old female presenting with primary amenorrhea due to Müllerian aplasia, dysmorphic features, and intellectual disability. Trio whole genome sequencing identified a pathogenic de novo missense variant in NM_003073.5( SMARCB1 ): c.1096C>T, p.(Arg366Cys) confirming the diagnosis of Coffin–Siris syndrome 3 (OMIM #614608). This patient represents the first molecularly confirmed case of Coffin–Siris syndrome presenting with Müllerian aplasia; however, two previous clinical reports support this potential rare association. Research is needed to further investigate this possible association, determine the prevalence of Müllerian aplasia in adolescent/adult female patients with Coffin–Siris syndrome and whether it may be associated with other BAF (BRG1/BRM‐associated factor) complex genes than SMARCB1 . Finally, it is unknown how BAF complex dysfunction may be involved in perturbed Müllerian duct development in females.
- 28 September 2026
- Published by Wiley in Clinical Genetics
Open AccessMüllerian Duct Aplasia in a Girl With SMARCB1 ‐Related Coffin–Siris Syndrome: A Rare Co‐Occurring Anomaly
Genetic etiologies of Müllerian aplasia (Mayer–Rokitansky–Küster–Hauser syndrome) remain poorly understood. Identification of patients with monogenic syndromes presenting with Müllerian aplasia may help improve our knowledge of the underlying biology. We investigated a 15‐year‐old female presenting with primary amenorrhea due to Müllerian aplasia, dysmorphic features, and intellectual disability. Trio whole genome sequencing identified a pathogenic de novo missense variant in NM_003073.5( SMARCB1 ): c.1096C>T, p.(Arg366Cys) confirming the diagnosis of Coffin–Siris syndrome 3 (OMIM #614608). This patient represents the first molecularly confirmed case of Coffin–Siris syndrome presenting with Müllerian aplasia; however, two previous clinical reports support this potential rare association. Research is needed to further investigate this possible association, determine the prevalence of Müllerian aplasia in adolescent/adult female patients with Coffin–Siris syndrome and whether it may be associated with other BAF (BRG1/BRM‐associated factor) complex genes than SMARCB1 . Finally, it is unknown how BAF complex dysfunction may be involved in perturbed Müllerian duct development in females.
- 1 August 2021
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (8) , 2134-2141
Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer
- 1 August 2021
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (8) , 2134-2141
Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer
- 10 April 2019
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (9) , 1139-1147
Conservative treatment of rectosigmoid endometriosis: A prospective study
Introduction: Deep infiltrating endometriosis is a common cause of pelvic pain. However, some patients have limited problems that may be controlled by medical treatment, so avoiding the potentially severe complications of major surgery. This approach requires detailed knowledge on quality of life and clinical symptoms over time. The aim of the study was to monitor these parameters in patients with rectosigmoid endometriosis treated with oral contraceptives, oral gestagens, and/or the levonorgestrel‐releasing intrauterine device. Moreover, nodule size measurements performed with transvaginal sonography were correlated to severity of symptoms.Material and methods: Conservatively treated patients on oral contraceptives, oral gestagens, or the levonorgestrel‐releasing intrauterine device underwent transvaginal sonography and answered a self‐administered questionnaire regarding clinical symptoms and quality of life (Short Form 36 and Endometriosis Health Profile 30) at baseline, and 6 and 12 months later.Results: Eighty women completed the follow up. Scores of quality of life were comparable to normative data for Danish women of similar age and did not change with time. No association between change in size of the rectosigmoid nodule and change in symptoms was seen.Conclusions: This study supports that simple treatment with oral contraceptives, oral gestagens, or the levonorgestrel‐releasing intrauterine device represents a viable therapeutic approach to rectosigmoid Deep infiltrating endometriosis, provided that proper selection of patients in need of surgery exists.
- 10 April 2019
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (9) , 1139-1147
Conservative treatment of rectosigmoid endometriosis: A prospective study
Introduction: Deep infiltrating endometriosis is a common cause of pelvic pain. However, some patients have limited problems that may be controlled by medical treatment, so avoiding the potentially severe complications of major surgery. This approach requires detailed knowledge on quality of life and clinical symptoms over time. The aim of the study was to monitor these parameters in patients with rectosigmoid endometriosis treated with oral contraceptives, oral gestagens, and/or the levonorgestrel‐releasing intrauterine device. Moreover, nodule size measurements performed with transvaginal sonography were correlated to severity of symptoms.Material and methods: Conservatively treated patients on oral contraceptives, oral gestagens, or the levonorgestrel‐releasing intrauterine device underwent transvaginal sonography and answered a self‐administered questionnaire regarding clinical symptoms and quality of life (Short Form 36 and Endometriosis Health Profile 30) at baseline, and 6 and 12 months later.Results: Eighty women completed the follow up. Scores of quality of life were comparable to normative data for Danish women of similar age and did not change with time. No association between change in size of the rectosigmoid nodule and change in symptoms was seen.Conclusions: This study supports that simple treatment with oral contraceptives, oral gestagens, or the levonorgestrel‐releasing intrauterine device represents a viable therapeutic approach to rectosigmoid Deep infiltrating endometriosis, provided that proper selection of patients in need of surgery exists.
- 15 February 2017
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 96 (6) , 745-750
Conservative approach to rectosigmoid endometriosis: a cohort study
Introduction: The aim of the study was to assess the risk of surgery after initial conservative treatment of rectosigmoid endometriosis in relation to demographic data.Material and methods: The study was conducted on the tertiary endometriosis referral unit, Aarhus University Hospital. Medical records, from patients seen from January 2009 onwards with a diagnosis of rectosigmoid endometriosis and more than 6 months’ follow up were audited. Demographic data, results of magnetic resonance imaging and time to secondary surgery for rectosigmoid endometriosis were registered.Results: Data on 238 patients diagnosed with rectosigmoid endometriosis were included. In all, 78 (32.8%) patients had primary surgery, 27 (11.3%) had secondary surgery and 133 (55.9%) continued conservative treatment throughout the observation period. Patients who underwent primary or secondary surgery were younger than patients continuing conservative treatment.Conclusions: In a tertiary referral center where about half of patients with rectosigmoid endometriosis were scheduled for conservative treatment, more than 80% of these avoided surgery.
- 15 February 2017
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 96 (6) , 745-750
Conservative approach to rectosigmoid endometriosis: a cohort study
Introduction: The aim of the study was to assess the risk of surgery after initial conservative treatment of rectosigmoid endometriosis in relation to demographic data.Material and methods: The study was conducted on the tertiary endometriosis referral unit, Aarhus University Hospital. Medical records, from patients seen from January 2009 onwards with a diagnosis of rectosigmoid endometriosis and more than 6 months’ follow up were audited. Demographic data, results of magnetic resonance imaging and time to secondary surgery for rectosigmoid endometriosis were registered.Results: Data on 238 patients diagnosed with rectosigmoid endometriosis were included. In all, 78 (32.8%) patients had primary surgery, 27 (11.3%) had secondary surgery and 133 (55.9%) continued conservative treatment throughout the observation period. Patients who underwent primary or secondary surgery were younger than patients continuing conservative treatment.Conclusions: In a tertiary referral center where about half of patients with rectosigmoid endometriosis were scheduled for conservative treatment, more than 80% of these avoided surgery.
- 6 November 2015
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (1) , 55-64
Assessment of myometrial invasion in endometrial cancer using three‐dimensional ultrasound and magnetic resonance imaging
Introduction: Preoperative knowledge of myometrial invasion in endometrial cancer is important for surgical planning. This study aimed to assess the diagnostic efficiency of two‐dimensional (2D) and three‐dimensional (3D) transvaginal ultrasonography (TVS) with and without saline infusion (SIS) and magnetic resonance imaging (MRI) for assessment of myometrial invasion in endometrial cancer.Material and methods: 110 women with atypical endometrial hyperplasia or endometrial adenocarcinoma underwent preoperative 2D‐ and 3D‐TVS with and without SIS and MRI. Offline 3D‐TVS measurement was performed of the minimal tumor‐free margin in relation to myometrial thickness expressed as deep (≥50%) myometrial invasion and subjective impression of cervix involvement. The quality of images was also evaluated. Diagnostic efficiencies were calculated for myometrial and cervical involvement for each method. The pathologist's final diagnosis served as the reference standard.Results: For myometrial involvement, MRI showed greater accuracy than 3D‐TVS or 2D‐TVS (83, 71 and 75%, respectively). The efficiency of 3D‐TVS was not superior to 2D‐TVS and did not improve with SIS. The sensitivities of 2D‐TVS and 3D‐TVS were similar to that of MRI, and the efficiency of 3D‐TVS improved when volumes of inadequate quality (39%) were excluded. For evaluating cervical involvement, the accuracy of 3D‐TVS was 85%, comparable to the results of 2D‐TVS (80%) and MRI (85%). The results did not improve when saline was added.Conclusion: 3D‐TVS or 3D‐SIS was not more efficient than 2D‐TVS or MRI for assessment of myometrial invasion in endometrial cancer. 3D‐TVS assessment without 2D‐TVS was impeded by difficulties in obtaining 3D‐TVS volumes of sufficient quality.
- 6 November 2015
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (1) , 55-64
Assessment of myometrial invasion in endometrial cancer using three‐dimensional ultrasound and magnetic resonance imaging
Introduction: Preoperative knowledge of myometrial invasion in endometrial cancer is important for surgical planning. This study aimed to assess the diagnostic efficiency of two‐dimensional (2D) and three‐dimensional (3D) transvaginal ultrasonography (TVS) with and without saline infusion (SIS) and magnetic resonance imaging (MRI) for assessment of myometrial invasion in endometrial cancer.Material and methods: 110 women with atypical endometrial hyperplasia or endometrial adenocarcinoma underwent preoperative 2D‐ and 3D‐TVS with and without SIS and MRI. Offline 3D‐TVS measurement was performed of the minimal tumor‐free margin in relation to myometrial thickness expressed as deep (≥50%) myometrial invasion and subjective impression of cervix involvement. The quality of images was also evaluated. Diagnostic efficiencies were calculated for myometrial and cervical involvement for each method. The pathologist's final diagnosis served as the reference standard.Results: For myometrial involvement, MRI showed greater accuracy than 3D‐TVS or 2D‐TVS (83, 71 and 75%, respectively). The efficiency of 3D‐TVS was not superior to 2D‐TVS and did not improve with SIS. The sensitivities of 2D‐TVS and 3D‐TVS were similar to that of MRI, and the efficiency of 3D‐TVS improved when volumes of inadequate quality (39%) were excluded. For evaluating cervical involvement, the accuracy of 3D‐TVS was 85%, comparable to the results of 2D‐TVS (80%) and MRI (85%). The results did not improve when saline was added.Conclusion: 3D‐TVS or 3D‐SIS was not more efficient than 2D‐TVS or MRI for assessment of myometrial invasion in endometrial cancer. 3D‐TVS assessment without 2D‐TVS was impeded by difficulties in obtaining 3D‐TVS volumes of sufficient quality.
- 6 October 2008
- Vol. 170 (41) , 3213-6
[Magnetic resonance imaging of the female pelvis].
The use of magnetic resonance (MR) imaging of the female pelvis has expanded considerably over the past decade. We here review important indications, including congenital anomalies, benign and malignant diseases and special emphasis is given to the diagnostic value and possible limitations of MR. MR also plays an increasing role in minimal access surgery.
- 6 October 2008
- Vol. 170 (41) , 3213-6
[Magnetic resonance imaging of the female pelvis].
The use of magnetic resonance (MR) imaging of the female pelvis has expanded considerably over the past decade. We here review important indications, including congenital anomalies, benign and malignant diseases and special emphasis is given to the diagnostic value and possible limitations of MR. MR also plays an increasing role in minimal access surgery.